CSI Market
Sign In | Register

Creative Medical Technology Holdings Inc (CELZ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CELZ Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Creative Medical Technology Holdings Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-2.91
Depreciation & amortization0.00
Amortization of Other Assets0.05
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Change In Fair Value Of Derivatives Liabilities-
Loss On Extinguishment Of Convertible Notes Payable-
Dividends Share Based Compensation-
Stock Based Compensations-
Liabilities Fair Value Adjustment-
Amortization Of Note Receivable Premium0.00
Income taxes0.00
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.01
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital-0.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.13
Discontinued operations0.00
Net Cash flow from Operating Activities-2.80
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Proceeds From Redemptions Of Certificates Of Deposit-
Payment To Acquire Patent Purchase Obligation Related Party-
Payment Of Patent Purchase Obligation Related Party-
Payments to Acquire Restricted Certificates of Deposit0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-0.13
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable-0.05
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.18
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.46
Proceeds from Contributions from Parent0.01
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Subscription Receivable-
Proceeds From Issuance Of Common Stock-
Prepayment Premium Paid On Convertible Debt-
Payments On Convertible Notes Payable-
Proceeds From Convertible Notes Payable-
Payments On Notes Payable-
Payment Of Offering Costs-
Preferred Stock Redemption Premium-
Payment Of Deferred Offering Costs-
Proceeds From Issuance Of Common Stock And Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.48
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.80
Total Cash Flow1.51
4 historic quarters locked

Sign in to unlock the full Creative Medical Technology Holdings Inc cash flow history.

Sign In Create Free Account

About Creative Medical Technology Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 7, 2026
  • Source: celz_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001477932-26-004779

Figures are derived from filed reports and may be restated. Historical data is subject to revision.